ZBIO:NSD-ProShares UltraPro Short Nasdaq Biotechnology (USD)

ETF | Trading--Inverse Equity | NSD

Last Closing Price

USD 10.02

Change

0.00 (0.00)%

Market Cap

USD 2.51M

Volume

0.03M

Average Target Price

N/A
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

The investment seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the NASDAQ Biotechnology Index®. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

Company Website : http://www.proshares.com

Currency: USD

Country : USA

Inception Date: 22/06/2015

Primary Benchmark: NASDAQ Biotechnology TR USD

Primary Index: S&P 500 TR USD

Management Expense Ratio: 0.95 %

Technical Indicators

Beta : -2.35

52 Week High : 18.64

52 Week Low : 8.28

Shorted Shares : 5,100

200 Day Moving Average : 10.14

50 Day Moving Average : 10.02

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
AMGN Amgen Inc 8.15 %
GILD Gilead Sciences, Inc 7.42 %
VRTX Vertex Pharmaceuticals Incorporated 7.22 %
BIIB Biogen Inc 6.13 %
ILMN Illumina, Inc 5.68 %
REGN Regeneron Pharmaceuticals, Inc 4.14 %
ALXN Alexion Pharmaceuticals, Inc 3.02 %
SGEN Seagen Inc 2.25 %
INCY Incyte Corporation 2.09 %
BMRN BioMarin Pharmaceutical Inc 1.91 %
Top Sectors

N/A

Top Regions

N/A

Valuation Growth & Performance

Morningstar Ratio : 0

Category Benchmark : S&P 500 TR USD

Sustainability Ratio :

3 Year Volatility : 61.20

3 Year Expected Return : 0.00

3 Year Sharpe Ratio : -0.38

YTD Return : 9.39%

3 Year Returns : -34.11%

5 Year Returns : 0.00%

10 Year Returns : 0.00%

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-03-07 )

Largest Industry Peers for Trading--Inverse Equity

Symbol Name Mer Price(Change) Market Cap
SQQQ ProShares UltraPro Short QQQ 0.95 %

N/A

 USD1.69B
BIS ProShares UltraShort Nasdaq Bi.. 0.95 %

N/A

 USD0.01B

ETFs Containing ZBIO

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Trading--Inverse Equity)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 10.62% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.62% N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain -73.58% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return -73.58% N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -12.64% N/A N/A N/A N/A
Dividend Return 0.06% N/A N/A N/A N/A
Total Return -12.58% N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 38.30% N/A N/A N/A N/A
Risk Adjusted Return -32.84% N/A N/A N/A N/A
Market Capitalization 2.51M N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike